首页> Cancer Chemotherapy and Pharmacology> A method for optimizing dosage regimens in oncology by visualizing the safety and efficacy response surface: analysis of inotuzumab ozogamicin

A method for optimizing dosage regimens in oncology by visualizing the safety and efficacy response surface: analysis of inotuzumab ozogamicin

导出原文传递

翻译打印收藏纠错

第一作者： Luu, Kenneth T.

作者： Luu, Kenneth T. ^[1] ; Boni, Joseph ^[2]

作者单位： Pfizer Oncol, Dept Clin Pharmacol, 500 Arcola Rd, Collegeville, PA 19426 USA ^[1] Pfizer Oncol, Dept Clin Pharmacol, La Jolla, CA USA ^[2]

关键词 Inotuzumab ozogamicin Pharmacokinetics Pharmacodynamics Dose optimization Non-Hodgkin lymphoma Clinical utility index

发布时间 2017-04-06

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Cancer Chemotherapy and Pharmacology

2016年78卷4期

697-708页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览2

点击下载本期目录封面

Cancer Chemotherapy and Pharmacology

2016年78卷4期

697-708页

检索历史清除

A method for optimizing dosage regimens in oncology by visualizing the safety and efficacy response surface: analysis of inotuzumab ozogamicin

Cancer Chemotherapy and Pharmacology

相似文献

同项目论文

Cancer Chemotherapy and Pharmacology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A method for optimizing dosage regimens in oncology by visualizing the safety and efficacy response surface: analysis of inotuzumab ozogamicin

Cancer Chemotherapy and Pharmacology

相似文献

同项目论文

Cancer Chemotherapy and Pharmacology

相关期刊

检索历史清除